Medicine
fromNews Center
2 weeks agoExperimental Drug Shows Promise for Rare Genetic Disorder - News Center
Tividenofusp alfa markedly reduced heparan sulfate levels and improved hearing in boys with MPS II, addressing both neurological and systemic disease manifestations.